Pharmacogenetic and environmental determinants of response to HMG-CoA reductase inhibitors.
A total of 146 Chinese patients with various degrees of hyperlipidaemia and high cardiovascular risk, suitable for treatment with rosuvastatin 10 mg daily and in whom it was possible to obtain baseline lipid profiles measured on no lipid lowering drug, were enrolled in to the study. The drug complia...
| Other Authors: | |
|---|---|
| Format: | Others |
| Language: | English Chinese |
| Published: |
2007
|
| Subjects: | |
| Online Access: | http://library.cuhk.edu.hk/record=b6074340 http://repository.lib.cuhk.edu.hk/en/item/cuhk-343969 |